427 related articles for article (PubMed ID: 33597014)
1. Alzheimer's disease brain contains tau fractions with differential prion-like activities.
Li L; Shi R; Gu J; Tung YC; Zhou Y; Zhou D; Wu R; Chu D; Jin N; Deng K; Xu J; Gong CX; Iqbal K; Liu F
Acta Neuropathol Commun; 2021 Feb; 9(1):28. PubMed ID: 33597014
[TBL] [Abstract][Full Text] [Related]
2. Pathological Alterations of Tau in Alzheimer's Disease and 3xTg-AD Mouse Brains.
Li L; Jiang Y; Hu W; Tung YC; Dai C; Chu D; Gong CX; Iqbal K; Liu F
Mol Neurobiol; 2019 Sep; 56(9):6168-6183. PubMed ID: 30734228
[TBL] [Abstract][Full Text] [Related]
3. Truncation of Tau selectively facilitates its pathological activities.
Gu J; Xu W; Jin N; Li L; Zhou Y; Chu D; Gong CX; Iqbal K; Liu F
J Biol Chem; 2020 Oct; 295(40):13812-13828. PubMed ID: 32737201
[TBL] [Abstract][Full Text] [Related]
4. Pathological Tau From Alzheimer's Brain Induces Site-Specific Hyperphosphorylation and SDS- and Reducing Agent-Resistant Aggregation of Tau
Miao J; Shi R; Li L; Chen F; Zhou Y; Tung YC; Hu W; Gong CX; Iqbal K; Liu F
Front Aging Neurosci; 2019; 11():34. PubMed ID: 30890929
[TBL] [Abstract][Full Text] [Related]
5. Pathological Changes of Tau Related to Alzheimer's Disease.
Chu D; Liu F
ACS Chem Neurosci; 2019 Feb; 10(2):931-944. PubMed ID: 30346708
[TBL] [Abstract][Full Text] [Related]
6. Tau antibody 77G7 targeting microtubule binding domain suppresses proteopathic tau to seed tau aggregation.
Li L; Miao J; Chu D; Jin N; Tung YC; Dai CL; Hu W; Gong CX; Iqbal K; Liu F
CNS Neurosci Ther; 2022 Dec; 28(12):2245-2259. PubMed ID: 36114722
[TBL] [Abstract][Full Text] [Related]
7. Tau-proximity ligation assay reveals extensive previously undetected pathology prior to neurofibrillary tangles in preclinical Alzheimer's disease.
Bengoa-Vergniory N; Velentza-Almpani E; Silva AM; Scott C; Vargas-Caballero M; Sastre M; Wade-Martins R; Alegre-Abarrategui J
Acta Neuropathol Commun; 2021 Jan; 9(1):18. PubMed ID: 33509301
[TBL] [Abstract][Full Text] [Related]
8. Aβ-induced acceleration of Alzheimer-related τ-pathology spreading and its association with prion protein.
Gomes LA; Hipp SA; Rijal Upadhaya A; Balakrishnan K; Ospitalieri S; Koper MJ; Largo-Barrientos P; Uytterhoeven V; Reichwald J; Rabe S; Vandenberghe R; von Arnim CAF; Tousseyn T; Feederle R; Giudici C; Willem M; Staufenbiel M; Thal DR
Acta Neuropathol; 2019 Dec; 138(6):913-941. PubMed ID: 31414210
[TBL] [Abstract][Full Text] [Related]
9. Hyperphosphorylation determines both the spread and the morphology of tau pathology.
Hu W; Zhang X; Tung YC; Xie S; Liu F; Iqbal K
Alzheimers Dement; 2016 Oct; 12(10):1066-1077. PubMed ID: 27133892
[TBL] [Abstract][Full Text] [Related]
10. Seeding-Competent Tau in Gray Matter Versus White Matter of Alzheimer's Disease Brain.
Wu R; Gu J; Zhou D; Tung YC; Jin N; Chu D; Hu W; Wegiel J; Gong CX; Iqbal K; Liu F
J Alzheimers Dis; 2021; 79(4):1647-1659. PubMed ID: 33459649
[TBL] [Abstract][Full Text] [Related]
11. Tau seeding activity begins in the transentorhinal/entorhinal regions and anticipates phospho-tau pathology in Alzheimer's disease and PART.
Kaufman SK; Del Tredici K; Thomas TL; Braak H; Diamond MI
Acta Neuropathol; 2018 Jul; 136(1):57-67. PubMed ID: 29752551
[TBL] [Abstract][Full Text] [Related]
12. Prevention of tau seeding and propagation by immunotherapy with a central tau epitope antibody.
Albert M; Mairet-Coello G; Danis C; Lieger S; Caillierez R; Carrier S; Skrobala E; Landrieu I; Michel A; Schmitt M; Citron M; Downey P; Courade JP; Buée L; Colin M
Brain; 2019 Jun; 142(6):1736-1750. PubMed ID: 31038156
[TBL] [Abstract][Full Text] [Related]
13. Extracellular Vesicles Containing P301L Mutant Tau Accelerate Pathological Tau Phosphorylation and Oligomer Formation but Do Not Seed Mature Neurofibrillary Tangles in ALZ17 Mice.
Baker S; Polanco JC; Götz J
J Alzheimers Dis; 2016 Oct; 54(3):1207-1217. PubMed ID: 27567840
[TBL] [Abstract][Full Text] [Related]
14. Templated misfolding of Tau by prion-like seeding along neuronal connections impairs neuronal network function and associated behavioral outcomes in Tau transgenic mice.
Stancu IC; Vasconcelos B; Ris L; Wang P; Villers A; Peeraer E; Buist A; Terwel D; Baatsen P; Oyelami T; Pierrot N; Casteels C; Bormans G; Kienlen-Campard P; Octave JN; Moechars D; Dewachter I
Acta Neuropathol; 2015 Jun; 129(6):875-94. PubMed ID: 25862635
[TBL] [Abstract][Full Text] [Related]
15. Metformin Attenuates Tau Pathology in Tau-Seeded PS19 Mice.
Zhao S; Fan Z; Zhang X; Li Z; Shen T; Li K; Yan Y; Yuan Y; Pu J; Tian J; Liu Z; Chen Y; Zhang B
Neurotherapeutics; 2023 Mar; 20(2):452-463. PubMed ID: 36422837
[TBL] [Abstract][Full Text] [Related]
16. Minimalistic in vitro systems for investigating tau pathology.
Hallinan GI; Pitera AP; Patel P; West J; Deinhardt K
J Neurosci Methods; 2019 May; 319():69-76. PubMed ID: 30278185
[TBL] [Abstract][Full Text] [Related]
17. Alzheimer PHF-tau aggregates do not spread tau pathology to the brain via the Retino-tectal projection after intraocular injection in male mouse models.
de Fisenne MA; Yilmaz Z; De Decker R; Suain V; Buée L; Ando K; Brion JP; Leroy K
Neurobiol Dis; 2022 Nov; 174():105875. PubMed ID: 36154878
[TBL] [Abstract][Full Text] [Related]
18. Tau as a therapeutic target for Alzheimer's disease.
Boutajangout A; Sigurdsson EM; Krishnamurthy PK
Curr Alzheimer Res; 2011 Sep; 8(6):666-77. PubMed ID: 21679154
[TBL] [Abstract][Full Text] [Related]
19. The twenty-four KDa C-terminal tau fragment increases with aging in tauopathy mice: implications of prion-like properties.
Matsumoto SE; Motoi Y; Ishiguro K; Tabira T; Kametani F; Hasegawa M; Hattori N
Hum Mol Genet; 2015 Nov; 24(22):6403-16. PubMed ID: 26374846
[TBL] [Abstract][Full Text] [Related]
20. Molecular Mechanisms in the Pathogenesis of Alzheimer's disease and Tauopathies-Prion-Like Seeded Aggregation and Phosphorylation.
Hasegawa M
Biomolecules; 2016 Apr; 6(2):. PubMed ID: 27136595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]